Georges P Hajj1, Yi Chu1, Donald D Lund1, Jason A Magida1, Nathan D Funk1, Robert M Brooks1, Gary L Baumbach1, Kathy A Zimmerman1, Melissa K Davis1, Ramzi N El Accaoui1, Tariq Hameed1, Hardik Doshi1, BiYi Chen1, Leslie A Leinwand1, Long-Sheng Song1, Donald D Heistad2, Robert M Weiss2. 1. From the Department of Internal Medicine (G.P.H., Y.C., D.D.L., N.D.F., R.M.B., K.A.Z., M.K.D., R.N.E.A., T.H., H.D., B.C., L.-S.S., D.D.H., R.M.W.), Department of Pharmacology (D.D.H.), and Department of Pathology (G.L.B.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City; and Department of Molecular, Cellular, and Developmental Biology (J.A.M., L.A.L., D.D.H.), University of Colorado, Boulder. 2. From the Department of Internal Medicine (G.P.H., Y.C., D.D.L., N.D.F., R.M.B., K.A.Z., M.K.D., R.N.E.A., T.H., H.D., B.C., L.-S.S., D.D.H., R.M.W.), Department of Pharmacology (D.D.H.), and Department of Pathology (G.L.B.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City; and Department of Molecular, Cellular, and Developmental Biology (J.A.M., L.A.L., D.D.H.), University of Colorado, Boulder. robert-weiss@uiowa.edu donald-heistad@uiowa.edu.
Abstract
OBJECTIVE: We studied the mechanistic links between fibrocalcific changes in the aortic valve and aortic valve function in mice homozygous for a hypomorphic epidermal growth factor receptor mutation (Wave mice). We also studied myocardial responses to aortic valve dysfunction in Wave mice. APPROACH AND RESULTS: At 1.5 months of age, before development of valve fibrosis and calcification, aortic regurgitation, but not aortic stenosis, was common in Wave mice. Aortic valve fibrosis, profibrotic signaling, calcification, osteogenic markers, lipid deposition, and apoptosis increased dramatically by 6 and 12 months of age in Wave mice. Aortic regurgitation remained prevalent, however, and aortic stenosis was rare, at all ages. Proteoglycan content was abnormally increased in aortic valves of Wave mice at all ages. Treatment with pioglitazone prevented abnormal valve calcification, but did not protect valve function. There was significant left ventricular volume overload, hypertrophy, and fetal gene expression, at all ages in Wave mice with aortic regurgitation. Left ventricular systolic function was normal until 6 months of age in Wave mice, but became impaired by 12 months of age. Myocardial transverse tubules were normal in the presence of left ventricular hypertrophy at 1.5 and 3 months of age, but became disrupted by 12 months of age. CONCLUSIONS: We present the first comprehensive phenotypic and molecular characterization of spontaneous aortic regurgitation and volume-overload cardiomyopathy in an experimental model. In Wave mice, fibrocalcific changes are not linked to valve dysfunction and are epiphenomena arising from structurally incompetent myxomatous valves.
OBJECTIVE: We studied the mechanistic links between fibrocalcific changes in the aortic valve and aortic valve function in mice homozygous for a hypomorphic epidermal growth factor receptor mutation (Wavemice). We also studied myocardial responses to aortic valve dysfunction in Wavemice. APPROACH AND RESULTS: At 1.5 months of age, before development of valve fibrosis and calcification, aortic regurgitation, but not aortic stenosis, was common in Wavemice. Aortic valve fibrosis, profibrotic signaling, calcification, osteogenic markers, lipid deposition, and apoptosis increased dramatically by 6 and 12 months of age in Wavemice. Aortic regurgitation remained prevalent, however, and aortic stenosis was rare, at all ages. Proteoglycan content was abnormally increased in aortic valves of Wavemice at all ages. Treatment with pioglitazone prevented abnormal valve calcification, but did not protect valve function. There was significant left ventricular volume overload, hypertrophy, and fetal gene expression, at all ages in Wavemice with aortic regurgitation. Left ventricular systolic function was normal until 6 months of age in Wavemice, but became impaired by 12 months of age. Myocardial transverse tubules were normal in the presence of left ventricular hypertrophy at 1.5 and 3 months of age, but became disrupted by 12 months of age. CONCLUSIONS: We present the first comprehensive phenotypic and molecular characterization of spontaneous aortic regurgitation and volume-overload cardiomyopathy in an experimental model. In Wavemice, fibrocalcific changes are not linked to valve dysfunction and are epiphenomena arising from structurally incompetent myxomatous valves.
Authors: B Chen; R T Bronson; L D Klaman; T G Hampton; J F Wang; P J Green; T Magnuson; P S Douglas; J P Morgan; B G Neel Journal: Nat Genet Date: 2000-03 Impact factor: 38.330
Authors: Steven A Crone; You-Yang Zhao; Lian Fan; Yusu Gu; Susumu Minamisawa; Yang Liu; Kirk L Peterson; Ju Chen; Ronald Kahn; Gianluigi Condorelli; John Ross; Kenneth R Chien; Kuo-Fee Lee Journal: Nat Med Date: 2002-05 Impact factor: 53.440
Authors: Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern Journal: J Mol Cell Cardiol Date: 2013-03-24 Impact factor: 5.000
Authors: Ang Guo; Xiaoying Zhang; Venkat Ramesh Iyer; Biyi Chen; Caimei Zhang; William J Kutschke; Robert M Weiss; Clara Franzini-Armstrong; Long-Sheng Song Journal: Proc Natl Acad Sci U S A Date: 2014-08-04 Impact factor: 11.205
Authors: Valentina Dargam; Hooi Hooi Ng; Sana Nasim; Daniel Chaparro; Camila Iansen Irion; Suhas Rathna Seshadri; Armando Barreto; Zachary C Danziger; Lina A Shehadeh; Joshua D Hutcheson Journal: Front Cardiovasc Med Date: 2022-05-25
Authors: Robert M Weiss; Yi Chu; Robert M Brooks; Donald D Lund; Justine Cheng; Kathy A Zimmerman; Melissa K Kafa; Phanicharan Sistla; Hardik Doshi; Jian Q Shao; Ramzi N El Accaoui; Catherine M Otto; Donald D Heistad Journal: J Am Heart Assoc Date: 2018-06-30 Impact factor: 5.501